1. Home
  2. NSPR vs LIDR Comparison

NSPR vs LIDR Comparison

Compare NSPR & LIDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • LIDR
  • Stock Information
  • Founded
  • NSPR 2005
  • LIDR 2013
  • Country
  • NSPR United States
  • LIDR United States
  • Employees
  • NSPR N/A
  • LIDR N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • LIDR Auto Parts:O.E.M.
  • Sector
  • NSPR Health Care
  • LIDR Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • LIDR Nasdaq
  • Market Cap
  • NSPR 101.8M
  • LIDR 108.6M
  • IPO Year
  • NSPR N/A
  • LIDR N/A
  • Fundamental
  • Price
  • NSPR $2.38
  • LIDR $2.67
  • Analyst Decision
  • NSPR Strong Buy
  • LIDR Strong Buy
  • Analyst Count
  • NSPR 2
  • LIDR 1
  • Target Price
  • NSPR $4.50
  • LIDR $6.00
  • AVG Volume (30 Days)
  • NSPR 79.2K
  • LIDR 5.7M
  • Earning Date
  • NSPR 11-11-2025
  • LIDR 11-11-2025
  • Dividend Yield
  • NSPR N/A
  • LIDR N/A
  • EPS Growth
  • NSPR N/A
  • LIDR N/A
  • EPS
  • NSPR N/A
  • LIDR N/A
  • Revenue
  • NSPR $7,066,000.00
  • LIDR $236,000.00
  • Revenue This Year
  • NSPR $7.48
  • LIDR $2,677.23
  • Revenue Next Year
  • NSPR $104.39
  • LIDR $409.09
  • P/E Ratio
  • NSPR N/A
  • LIDR N/A
  • Revenue Growth
  • NSPR 7.60
  • LIDR N/A
  • 52 Week Low
  • NSPR $1.99
  • LIDR $0.49
  • 52 Week High
  • NSPR $3.80
  • LIDR $6.44
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 44.77
  • LIDR 48.95
  • Support Level
  • NSPR $2.35
  • LIDR $2.56
  • Resistance Level
  • NSPR $2.46
  • LIDR $3.22
  • Average True Range (ATR)
  • NSPR 0.08
  • LIDR 0.25
  • MACD
  • NSPR -0.00
  • LIDR -0.06
  • Stochastic Oscillator
  • NSPR 23.53
  • LIDR 11.83

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: